US FDA approves Pfizer’s pain-relief nasal spray for migraine
By Khushi Mandowara (Reuters) -The U.S. Food and Drug Administration on Friday approved Pfizer Inc’s nasal spray for migraine, giving patients access to a potentially fast-acting pain-relief option for headaches. The drug Zavzpret, also known as zavegepant, was approved for the treatment of acute migraine with or without aura in adults, the company said. Aura …
US FDA approves Pfizer’s pain-relief nasal spray for migraine Read More »